306 related articles for article (PubMed ID: 22431771)
1. Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
Lutz V; Lipsker D
Arch Dermatol; 2012 Mar; 148(3):297-9. PubMed ID: 22431771
[No Abstract] [Full Text] [Related]
2. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
Tobin AM; Kirby B
Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
[No Abstract] [Full Text] [Related]
4. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
Nikkels AF; Piérard GE
J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
[No Abstract] [Full Text] [Related]
5. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
Silpa-archa N; Wongpraparut C
J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
[TBL] [Abstract][Full Text] [Related]
6. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
Kazinski K; Joyce KM; Hodson D
J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
[TBL] [Abstract][Full Text] [Related]
7. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
[TBL] [Abstract][Full Text] [Related]
8. Repigmentation and curling of hair after acitretin therapy.
Seckin D; Yildiz A
Australas J Dermatol; 2009 Aug; 50(3):214-6. PubMed ID: 19659987
[TBL] [Abstract][Full Text] [Related]
9. New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra.
González-López MA; Martínez-Taboada VM; González-Vela MC; Fernández-Llaca H; Val-Bernal JF
Br J Dermatol; 2008 May; 158(5):1146-8. PubMed ID: 18284383
[No Abstract] [Full Text] [Related]
10. Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.
López-Ferrer A; Dalmau J; Fernández-Figueras MT; Puig L
Cutis; 2014 Mar; 93(3):E6-7. PubMed ID: 24738108
[No Abstract] [Full Text] [Related]
11. [Patient memo. Advice for patients with psoriasis and using Soriatane].
Rev Prat; 2004 Jan; 54(1):70. PubMed ID: 15049605
[No Abstract] [Full Text] [Related]
12. Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin.
Gallo E; Llamas-Velasco M; Daudén E; García-Diez A
Int J Dermatol; 2013 Dec; 52(12):1610-1. PubMed ID: 22834488
[No Abstract] [Full Text] [Related]
13. The trials of anakinra.
Burls A; Jobanputra P
Lancet; 2004 Sep 4-10; 364(9437):827-8. PubMed ID: 15351176
[No Abstract] [Full Text] [Related]
14. Acitretin.
Ortiz NE; Nijhawan RI; Weinberg JM
Dermatol Ther; 2013; 26(5):390-9. PubMed ID: 24099069
[TBL] [Abstract][Full Text] [Related]
15. Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
Khosravi-Hafshejani T; Zhou Y; Dutz JP
J Rheumatol; 2019 Apr; 46(4):437-438. PubMed ID: 30936225
[No Abstract] [Full Text] [Related]
16. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
Fleischmann RM; Schechtman J; Bennett R; Handel ML; Burmester GR; Tesser J; Modafferi D; Poulakos J; Sun G
Arthritis Rheum; 2003 Apr; 48(4):927-34. PubMed ID: 12687534
[TBL] [Abstract][Full Text] [Related]
17. Acrodermatitis Continua of Hallopeau with Granuloma-like Vegetation, Osteolysis and IL36RN Mutation.
Qi Y; Qiu L; Zheng S; Li S; Xiao T
Acta Derm Venereol; 2017 Jan; 97(1):122-123. PubMed ID: 27231138
[No Abstract] [Full Text] [Related]
18. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis?
Sahin MT; Oztürkcan S; Türel A; Kandiloğlu AR
J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):236-8. PubMed ID: 12705767
[No Abstract] [Full Text] [Related]
19. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
[TBL] [Abstract][Full Text] [Related]
20. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
[No Abstract] [Full Text] [Related]
[Next] [New Search]
